Simo Kitanovski, Gibran Horemheb-Rubio, Ortwin Adams, Barbara Gärtner, Thomas Lengauer, Daniel Hoffmann, . . . Respiratory Virus Network. (2021). Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2. BMC.
Chicago Style (17th ed.) CitationSimo Kitanovski, Gibran Horemheb-Rubio, Ortwin Adams, Barbara Gärtner, Thomas Lengauer, Daniel Hoffmann, Rolf Kaiser, and Respiratory Virus Network. Rhinovirus Prevalence as Indicator for Efficacy of Measures Against SARS-CoV-2. BMC, 2021.
MLA (9th ed.) CitationSimo Kitanovski, et al. Rhinovirus Prevalence as Indicator for Efficacy of Measures Against SARS-CoV-2. BMC, 2021.
Warning: These citations may not always be 100% accurate.